Lantheus Medical Imaging Announces First Commercial Production of Technelite(R) Generators from Low-Enriched Uranium-Produced Molybdenum-99

N. BILLERICA, Mass.--(BUSINESS WIRE)--Lantheus Medical Imaging, Inc., a worldwide leader in diagnostic medical imaging, today announced the first commercial production of TechneLite® (Technetium Tc99m Generator) generators using molybdenum-99 (Mo-99) produced with low-enriched uranium (LEU) targets, making Lantheus the first company to use Mo-99 sourced from LEU in the United States. Lantheus received the first commercial scale batch from NTP Radioisotopes Ltd. (NTP), a subsidiary of the Nuclear Energy Corporate of South Africa (NESCA).

Back to news